Avricore Health Inc

02/20/2026

The market for point-of-care diagnostics is expected to expand significantly by 2029, reflecting a global move toward quicker answers, earlier detection, and more patient-centered care.

Avricore is proud to be part of this momentum by helping to bring accessible testing directly into community pharmacies, supporting better outcomes for patients across the world.

02/11/2026

"The move reflects growing clinical demand and strong engagement from pharmacists, reinforcing a systemic shift that is turning the corner drugstore into a new frontline for tackling chronic disease."

This thoughtful piece from BriefGlance.com highlights HealthTab’s role in the NHS' commitment to transforming care as London pharmacies lead a new model for community-based cardiovascular health care.

🔗 Read the article: https://bit.ly/4qHtcfp

Rapid health checks are transforming cardiovascular care in London, as a new initiative expands to 70 pharmacies, shifting services from hospitals to the high street.

02/06/2026

As recently highlighted by the BBC, our community pharmacy testing pilot delivered with Barts Health showed that:

→ Of 1,000 people tested for cholesterol, 163 were identified as high risk of a heart attack or stroke.

→ 50 patients were started on cholesterol-lowering treatment directly through their pharmacy, without the need to go via their GP.

The trial's initial success brings an expansion to 70 more locations in east London, showing us that pharmacies can quickly become a powerful pathway to preventative and proactive care in the community with the harnessing of digital tools—directly speaking to the pillars of the NHS 10 Year Health Plan.

01/30/2026

Cardiovascular disease remains the UK’s biggest killer, but placing digital prevention in the community is a proven, scalable, and equitable way to change that.

As one part of UCLPartners' insights on steps to preventative innovation, putting "accessible prevention where people already are" is key to making it readily available and easily accessible.

Community pharmacies play a vital role by offering trusted walk-in care where people already go, especially in deprived areas. HealthTab helps enable this shift with its simple seven-minute lipid test placed in the community pharmacy, bringing prevention closer to home.

01/20/2026

📽️ Darren Jones MP recently shared an excellent video showing how community pharmacies in North East London are increasingly becoming a front door to prevention and it's encouraging to see the delivery of real access, closer to home: https://x.com/darrenpjones/status/2011014667922014566

After a successful pilot with Barts Health NHS Trust this past year, the programme is now expanding across North East London. We're excited to be bringing HealthTab’s simple 7-minute test to 70 more community pharmacies, making it easy for people to check their health and cardiovascular risk where convenience finds them.

01/15/2026

We’re pleased to announce the planned expansion of the HealthTab™ platform across North East London, with deployment to an additional 70 community pharmacy sites.

This reinforces our strategic focus on the UK and demonstrates the scalability of HealthTab within complex NHS environments. As pharmacy services continue to expand nationally, HealthTab is well positioned for further growth across England in both preventive and treatment-linked care pathways.

🔗 Read the full release: https://bit.ly/4sFkqjr

01/07/2026

In the NHS Priorities and Operational Planning Guidance for these two years of 2025/2026, prevention is a national priority that’s no longer optional.

Expanding access to community POCT and convenient monitoring can help close care gaps and support earlier intervention. With technologies like HealthTab, we’re bringing prevention closer to home, one pharmacy at a time.

12/31/2025

Before we kick off the new year, here is a brief of our #2025:

✅ Patients Know Best Partnership in Place

✅ Breakthrough UK Pharmacy Funding Developments

✅ HealthTab President Rodger Seccombe Appointed CEO

✅ NHS Inclisiran Pilot Launched

With platform expansion in the UK continuing to progress, new and strengthened partnerships in place, and positive movement in policy all contributing to great momentum, we’re well-placed for continued growth in 2026 and look forward to the exciting things that the new year will bring!

12/18/2025

The NHS is pushing for stronger cholesterol prevention delivered closer to home as a major strategy in its 10 Year Health Plan. Community pharmacy plays a key role in early detection and treatment, which is already being supported by POCT technologies like HealthTab.

We’re thrilled to see the NHS’ commitment to POCT and are proud to be a trusted contributor as we build the health system of the future.

12/09/2025

HealthTab’s simple 7-minute cholesterol test in community pharmacies is transforming heart health by making prevention accessible, trusted, and part of everyday life.

Now, with the introduction of Barts Health NHS Trust's inclisiran pilot—taking the injectable cholesterol treatment beyond just the hospital and into the community pharmacy—we’re working with our partners to develop a streamlined pathway for patients to be tested and treated in one place close to home.

📽️ Watch: https://www.youtube.com/watch?v=vP_FNOZ_bHU

Nyd de videoer og den musik, du holder af, upload originalt indhold, og del det hele med venner, familie og verden på YouTube.

11/28/2025

As a major step forward in the expansion of the HealthTab™ platform, we're thrilled to announce its deployment in a new pharmacy-led inclisiran delivery pilot launched by Barts Health NHS Trust with UCL Partners and the British Heart Foundation.

→ HealthTab enters secondary-prevention care inside the NHS—a major expansion from screening into therapy-linked workflows.

→ Integration with Ortus-iHealth connects HealthTab directly into hospital clinical systems, positioning the platform as core infrastructure for NHS pharmacy-based care.

→ Inclisiran pilot validates HealthTab as a trusted technology partner inside a high-profile cardiovascular program.

→ Significantly expands HealthTab’s addressable market by enabling participation in long-term lipid management pathways.

→ Strengthens Avricore’s position in UK community pharmacy networks, aligning perfectly with NHS policy to shift chronic-condition management into pharmacies.

11/27/2025

🤝 Leading manufacturers
🤝 Healthcare organizations
🤝 Pharmacy groups

By connecting innovation and patient care, we’re making preventive testing more accessible than ever.